Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy: A Placebo Controlled Randomized Study

NCT00492518 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00492518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00492518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy: A Placebo Controlled Randomized Study
Lead sponsor
Technical University of Munich
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2002
Completion date
October 31, 2004
Enrollment
254 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effects, contrast induced nephropathy, kidney diseases, renal failure